-
Aixtron Downgraded At Kepler Cheuvreux On Guidance Risk, 'No Catalyst In Sight'
Thursday, July 9, 2015 - 7:44am | 233Read More...In a report published Thursday, Kepler Cheuvreux analyst Bernd Laux downgraded the rating on AIXTRON SE (ADR) (NASDAQ: AIXG) from Hold to Reduce, while reducing the price target from EUR7 to EUR5, saying that 2015 guidance was at risk. Analyst Bernd Laux believes that Aixtron would report its 2Q...
-
Kepler Cheuvreux Upgrades ABB To Hold
Monday, June 8, 2015 - 10:19am | 49Read More...Kepler Cheuvreux upgraded ABB Ltd (ADR) (NYSE: ABB) from Reduce to Hold. ABB shares have dropped 3.76 percent over the past 52 weeks, while the S&P 500 index has surged 7.25 percent in the same period. ABB shares closed at $22.80 on Friday.
-
Pfizer's Heart Races Of AstraZeneca Amidst Rumored Deal & Drug Approval
Thursday, May 8, 2014 - 3:23pm | 937Read More...Pfizer (NYSE: PFE) continues to pursue AstraZeneca plc (NYSE: AZN) despite three rejections this year and grave concern by U.K. politicians. History Of Bids On May 1, 2014, Bloomberg reported that Pfizer could raise its bid for AstraZeneca to more than $106 billion (63 billion pounds) and...
-
Bayer Rumored To Sell Plastics Business For More Than $10.8B
Monday, April 28, 2014 - 3:23pm | 131Read More...Shares of Bayer AG (OTC: BAYRY) are up 3.2 percent to $134.31 on a first quarter earnings and a report from Bloomberg the company is said to be considering the sale of its $10 billion plastics unit. Evonik Industries expressed interest “some months ago, according to people with knowledge of the...
